kintara com login
Searching for kintara com login? Use official links below to sign-in to your account.
If there are any problems with kintara com login, check if password and username is written correctly. Also, you can contact with customer support and ask them for help. If you don't remember you personal data, use button "Forgot Password". If you don't have an account yet, please create a new one by clicking sign up button/link.
Kintara Therapeutics, Inc. (KTRA)
- https://www.kintara.com/
- Kintara Therapeutics leadership team is committed to contributing to the battle against cancer by researching and developing novel cancer therapies that treat patients with significant unmet clinical need. Management Team. Board of Directors. Advisors. Latest Press Releases.
- Status:Page Online
ADVFN - Free stock and cryptocurrency prices, charts ...
- https://www.advfn.com/
- FREE stock and cryptocurrency quotes, message boards, fundamentals. Markets include NASDAQ, NYSE, OTCBB, Pink Sheet, cryptocurrency and world exchanges. Use advanced charts, Level2, read market ...
- Status:Page Online
Pipeline :: Kintara Therapeutics, Inc. (KTRA)
- https://www.kintara.com/pipeline
- Our Development Pipeline. Kintara Therapeutics is focused on developing unique anti-cancer compounds, supported by a strong scientific rationale for development in indications with established biomarkers, and where patients are failing, or are unable to tolerate, current therapies.
- Status:Page Online
Privacy Policy :: Kintara Therapeutics, Inc. (KTRA)
- https://www.kintara.com/privacy-policy
- What Do We Do With The Information You Provide? We may ask you to give us contact and demographic information when you register. We use this information to send our Site's users like you information about the Site or Services.
- Status:Page Online
Kintara Therapeutics Presents Data at the 2022 American Association for ...
- https://www.kintara.com/news-media/press-releases/detail/990/kintara-therapeutics-presents-data-at-the-2022-american
- April 11, 2022 SAN DIEGO, April 11, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announces that it has presented data at the 2022 American Association for Cancer Research (AACR) Annual Meeting.
- Status:Page Online
Login to MjLink
- https://www.mjlink.com/login
- Login to MjLink MjLink Business Network Connect, learn, network and do business with other Cannabis industry professionals from around the world on the MjLink Business Social Network. Join Today!
- Status:Page Online
Kinrara Distillery - THE HOME OF HAND-CRAFTED HIGHLAND SPIRITS
- https://www.kinraradistillery.com/
- Kinrara Distillery is a Scottish craft gin producer set within the adventurous landscape of The Cairngorms, just outside the town of Aviemore. The Distillery takes its name from the surrounding Kinrara Estate, an area considered to have outstanding scenic and nature conservation value, as well as a high level of historical interest.
- Status:Page Online
Kintara Therapeutics, Inc. (NASDAQ:KTRA) Expected to Announce Earnings of ...
- https://www.defenseworld.net/2022/04/20/kintara-therapeutics-inc-nasdaqktra-expected-to-announce-earnings-of-0-15-per-share.html
- Analysts expect Kintara Therapeutics, Inc. (NASDAQ:KTRA - Get Rating) to post ($0.15) earnings per share (EPS) for the current quarter, according to Zacks. Zero analysts have issued estimates ...
- Status:Page Online
Zacks: Analysts Expect Kintara Therapeutics, Inc. (NASDAQ:KTRA) Will ...
- https://www.etfdailynews.com/2022/04/20/zacks-analysts-expect-kintara-therapeutics-inc-nasdaqktra-will-announce-earnings-of-0-15-per-share/
- Equities analysts forecast that Kintara Therapeutics, Inc. (NASDAQ:KTRA - Get Rating) will announce earnings per share of ($0.15) for the current fiscal quarter, Zacks reports. Zero analysts ...
- Status:Page Online
The Gypsy Cobs - dannishowers.wixsite.com
- https://dannishowers.wixsite.com/kintara/gypsies
- Kintara Sandstorm Clononeen VIP (imp) x Storm of Brackenhill (imp) Born October 2013 14.3hh Buckskin and White Tobiano Stallion (Negative PSSM) Meet Dune! Stormy outdid herself with this one, so much so that I'm thinking I'll keep him and run him on as a stallion. Beautifully put together, great feather coming in, fantastic nature, and all to ...
- Status:Page Online
Kintara - VentureRadar
- https://www.ventureradar.com/organisation/Kintara/ece50cc6-285a-4331-9057-e53b215f8d2b
- Kintara "Located in San Diego, California, Kintara (Nasdaq: KTRA) is dedicated to the development of novel cancer therapies for patients with rare unmet medical needs. Kintara is currently developing two Phase 3-ready therapeutics, VAL-083 for GBM and REM-001 for cutaneous metastatic breast cancer (CMBC).
- Status:Page Online
KINTARALAGI is on Mixlr. Mixlr is a simple way to share live audio...
- https://mixlr.com/kintaralagi
- KINTARALAGI is on Mixlr. Mixlr is a simple way to share live audio... KINTARALAGI's chat Welcome to Mixlr ! Please login or sign up to chat on KINTARALAGI's Mixlr page Sign up to Mixlr Already a member? Login
- Status:Page Online
About :: Kintara Therapeutics, Inc. (KTRA)
- https://www.kintara.com/about
- Kintara Therapeutics is dedicated to the development of novel cancer therapies for patients with unmet medical needs. Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel cancer therapies.
- Status:Page Online
KTRA | Stock Snapshot - Fidelity
- https://eresearch.fidelity.com/eresearch/goto/evaluate/snapshot.jhtml?symbols=KTRA
- Log in for more information Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a… View more Sector (GICS®) Health Care Industry (GICS®) Biotechnology
- Status:Page Online
Kintara Announces Closing of $8.6 Million Registered Direct Offering Priced ...
- https://www.wfmz.com/news/pr_newswire/pr_newswire_business/kintara-announces-closing-of-8-6-million-registered-direct-offering-priced-at-the-market-under/article_06f3024e-3dfa-5f81-9e72-1cffa9ed6def.html
- san diego, april 14, 2022 /prnewswire/ -- kintara therapeutics, inc. (nasdaq: ktra) ("kintara" or the "company"), a biopharmaceutical company focused on the development of new solid tumor cancer...
- Status:Page Online
Kintara | A Wheel of Time Wiki | Fandom
- https://wot.fandom.com/wiki/Kintara
- Kintara was a small nation that came into existence after the Hundred Years War . Location and mention Kintara was probably located in the Hills of Kintara. It was bordered to the south by Maredo, to the west by Murandy and to the north by Andor. Ingtar Shinowa mentions Kintara as one of the nations that have fallen into oblivion.
- Status:Page Online
Kintara Reports Topline Results From Phase 2 Clinical Trial of VAL-083 for ...
- https://www.prnewswire.com/news-releases/kintara-reports-topline-results-from-phase-2-clinical-trial-of-val-083-for-recurrent-gbm-301324046.html
- san diego, july 1, 2021 /prnewswire/ -- kintara therapeutics, inc. (nasdaq: ktra) ("kintara" or the "company"), a biopharmaceutical company developing novel cancer therapies for patients who are...
- Status:Page Online
Kintara Therapeutics Presents Data at the 2022 American Association for ...
- https://www.wfmz.com/news/pr_newswire/pr_newswire_business/kintara-therapeutics-presents-data-at-the-2022-american-association-for-cancer-research-annual-meeting/article_dc8773c3-e199-5d70-9e1f-08f753ab01de.html
- By Kintara Therapeutics SAN DIEGO, April 11, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of...
- Status:Page Online
Kintara Therapeutics Presents Data at the 2022 American Association for ...
- https://www.prnewswire.com/news-releases/kintara-therapeutics-presents-data-at-the-2022-american-association-for-cancer-research-annual-meeting-301522397.html
- About Kintara Located in San Diego, California, Kintara is dedicated to the development of novel cancer therapies for patients with unmet medical needs. Kintara is developing two late-stage, Phase ...
- Status:Page Online
Kintara Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/kintara-therapeutics
- Kintara Therapeutics is a developer of novel cancer therapies for patients with unmet medical needs. San Diego, California, United States 1-10 Post-IPO Equity Public www.kintara.com/ 72,870 Highlights Stock Symbol NASDAQ:KTRA Total Funding Amount $25M Contacts 1 Employee Profiles 3 Find More Contacts for Kintara Therapeutics Robert Toth Director
- Status:Page Online
Kintara Therapeutics Inc (KTRA) Quote - XNAS | Morningstar
- https://www.morningstar.com/stocks/xnas/ktra/quote
- Learn about Kintara Therapeutics Inc (KTRA:XNAS) stock quote with Morningstar's rating and analysis and stay up to date with the current news, price, valuation, dividends and other stock ...
- Status:Page Online
Kintara Therapeutics logo (PRNewsfoto/Kintara Therapeutics) | News | wfmz.com
- https://www.wfmz.com/news/pr_newswire/pr_newswire_stocks/kintara-therapeutics-logo-prnewsfoto-kintara-therapeutics/image_c2e7f362-8544-5c74-9524-7e5c47cc85a7.html
- Brand New App to watch all of WFMZ-TV News and Syndicated Programing 24/7 on your Streaming App enabled TV ...
- Status:Page Online
Kintara Therapeutics: KTRA Stock Price Quote & News - Robinhood
- https://robinhood.com/stocks/KTRA
- Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. It focuses on VAL-083 and REM-001 pipelines.
- Status:Page Online
Biotech catalyst calendars and drug pipelines • BioPharmCatalyst
- https://www.biopharmcatalyst.com/company/KTRA/news/76155
- About Kintara Located in San Diego, California, Kintara is dedicated to the development of novel cancer therapies for patients with unmet medical needs. Kintara is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for ...
- Status:Page Online
Kintara Announces Closing of $8.6 Million Registered Direct Offering Priced ...
- https://www.biospace.com/article/releases/kintara-announces-closing-of-8-6-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules/
- SAN DIEGO, April 14, 2022 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules with institutional investors for the purchase and sale of ...
- Status:Page Online
Kintara Therapeutics Set to Join Russell Microcap® Index
- https://www.prnewswire.com/news-releases/kintara-therapeutics-set-to-join-russell-microcap-index-301306592.html
- SAN DIEGO, June 7, 2021 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer ...
- Status:Page Online
Report Your Problem